Clinical Trials Directory

Trials / Completed

CompletedNCT00243048

Isoflavones and Radiation Therapy in Treating Patients With Localized Prostate Cancer

Phase II Randomized Study of Soy Isoflavones in Patients With Localized Prostate Cancer Treated With Radiation Therapy

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
70 (estimated)
Sponsor
Barbara Ann Karmanos Cancer Institute · Academic / Other
Sex
Male
Age
18 Years
Healthy volunteers
Not accepted

Summary

RATIONALE: Eating a diet high in soy foods may slow the progression of some types of cancer. Isoflavones are compounds found in soy food that may slow the growth of prostate cancer cells and prevent further development of prostate cancer. Radiation therapy uses high-energy x-rays to kill tumor cells. Giving isoflavones together with radiation therapy may be an effective treatment for prostate cancer. PURPOSE: This randomized phase II trial is studying the side effects and how well giving isoflavones together with radiation therapy works in treating patients with localized prostate cancer.

Detailed description

OBJECTIVES: * Determine the effect of soy protein isolate (isoflavones) and radiotherapy on the modulation of biomarkers in patients with localized prostate cancer. * Determine the toxicity of this regimen in these patients. * Determine the effect of this regimen on the quality of life of these patients. OUTLINE: This is a randomized, placebo-controlled study. Patients are randomized to 1 of 2 treatment arms. * Arm I: Patients receive oral soy protein isolate (isoflavones) twice daily for 6 months in the absence of disease progression or unacceptable toxicity. * Arm II: Patients receive an oral placebo twice daily for 6 months in the absence of disease progression or unacceptable toxicity. In both arms, patients also undergo radiotherapy while receiving isoflavones or placebo. Quality of life is assessed periodically. PROJECTED ACCRUAL: A total of 70 patients will be accrued for this study.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTsoy protein isolate
RADIATIONradiation therapy

Timeline

Start date
2002-05-01
Primary completion
2006-10-01
Completion
2007-10-01
First posted
2005-10-21
Last updated
2013-04-05

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00243048. Inclusion in this directory is not an endorsement.